Incyte Stock Price (NASDAQ:INCY)

Add to My Stocks
$124.28 $0.11 (0.09%) INCY stock closing price Apr 28, 2017 (Closing)
YOUR DAILY UPDATE ON
INCY
Incyte
28 APR 2017
amigobulls logo
INCY hand_up
INCY vs S&P 500
Closing Price: Apr 28, 2017
INCY
$124.28 ( 0.09%)
S&P 500
2384.2 ( -0.19%)
INCY
52 Week Price Range
1 Year Return: 71.65%
Q4 Growth*
Excellent
Profitable ?
Yes
net image
2016 Q4 Net Profit
9.4%
PE Valuation
Expensive*
home image
Rating
INCY EXCELLENT
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Incyte Snapshot Video

16 5 2

INCY Stock Details

Prev Close* : $124.17
Market Cap:
$25.4B
Day Low: $123.02
52 Week Low: $68.03
Open: $124.26
Volume: 977629
Day High: $124.8
52 Week High: $153.15
Dividend:
N/A

Incyte Stock Articles & Video

more news on INCY stock

Incyte News - From Partners

INCY Stockcharts

View INCY PE ratio, PS ratio stocks charts and compare with peers.
INCY Chart
Note: Compare Incyte stock price history with the index and industry peers.

Incyte Valuation

PE ratio
(price earnings ratio)
230.15
PS ratio (
price to sales ratio
)
21.2
PB ratio (
price to book ratio
)
78.9

Incyte Returns

ROE
(return on equity)
35%

Incyte Financial Ratios

Asset Turnover
0.82
Receivables Turnover
8.84
Debt to Equity
1.55

INCY Industry Peers

Company Price Change (%)
Csl Ltd (CMXHY)32.930.22 (0.67%)
Actelion (ALIOF)2698.2 (2.96%)
Pfizer (PFE)33.920.06 (0.18%)
Eli Lilly (LLY)82.060.73 (0.9%)
Novartis (NVS)77.030.03 (0.04%)
Geron (GERN)2.560.07 (2.66%)
Merck (MRK)62.330.25 (0.4%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MiMedx (MDXG)12.691.29 (11.32%)
Regeneron Pharma (REGN)388.4921.87 (5.97%)
Evogene (EVGN)5.360.3 (5.93%)
Sarepta Therapeutics (SRPT)36.261.54 (4.44%)
Acorda Therapeutics (ACOR)16.150.6 (3.86%)
Alkermes (ALKS)58.251.95 (3.46%)
Heska (HSKA)108.253.03 (2.88%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017
CompanyPriceChange (%)
Sorrento Therapeutics (SRNE)1.950.15 (7.14%)
Revance (RVNC)21.751.55 (6.65%)
ZIOPHARM Oncology (ZIOP)7.040.47 (6.26%)
Alder BioPharma (ALDR)20.051.3 (6.09%)
Mirati Therapeutics (MRTX)4.550.23 (4.82%)
Idera Pharma (IDRA)2.350.1 (4.08%)
Curis (CRIS)2.420.1 (3.97%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017

Incyte Corporation Stock News - Partner Headlines

Incyte Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.11B753.75M511.49M354.94M297.05M
Net Income104.22M6.53M-48.48M-83.14M-44.32M
Total Operating Expense902.53M676.12M513.29M370.41M295.75M
view Incyte Corporation income statement
balance sheet20162015201420132012
Total Assets1.64B1.01B830.06M629.56M330.41M
Total Liabilities1.22B836.28M911.69M822.67M505.37M
Shareholders Equity419.46M171.15M-81.62M-193.1M-174.95M
view Incyte Corporation balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities24.75M-34.84M-29.11M-4.48M-118.43M
Net Cash From (Used By) Operating Activities304.75M86.53M26.25M9.18M-94.83M
Increase (Decrease) In Prop Plant And Equipment-120.27M-26M-27.87M-4.26M-2.83M
view Incyte Corporation cashflow statement

Incyte Stock Message Board

Incyte stock price ended the last trading day at 124.17. Stock price or share price can be used to find the total market value of a company. Incyte market cap stands at 25.18B as of 27 Apr, 2017. Incyte valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy INCY stock than sell it, then Incyte stock price goes up. Conversely, if more investors wanted to sell INCY stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Incyte stock quote data shows the number of shares traded. For Ex: 1038137 Incyte shares were traded as of last trading day, as seen from Incyte stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Incyte stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.